Stockholm Stock Exchange | Large Cap
Vitrolife
+20.66%
Latest
+17.84%
3 months
CarnegieSEB EquitiesSEBHandelsbankenDNBHandelsbanken Capital MarketsDNB Markets

Price Targets For Vitrolife

AnalystPrice TargetDateUpside
Carnegie285 SEKOct 4
+20.66%
SEB Equities275 SEKOct 1
SEB275 SEKOct 1
Handelsbanken250 SEKJul 18
DNB250 SEKJul 18
Handelsbanken Capital Markets220 SEKJan 12
DNB Markets220 SEKJan 10

About The Company

Vitrolife is a Swedish medtech company which sells products for IVF treatment.
Wikipedia